ID,PublishedDate,Title,Abstract,PublicationName,Creator,Authors,Link,DOI,Availability,PII,lemmas_title,lemmas_abstract
DOI:10.1016/j.ando.2020.04.005,2020-04-21T00:00:00.000Z,Renin-angiotensin-aldosterone system and COVID-19 infection,"
               Abstract
               
                  With the multiplication of COVID-19 severe acute respiratory syndrome cases due to SARS COV2, some concerns about angiotensin-converting enzyme 1 (ACE1) inhibitors (ACEi) and angiotensin II type 1 receptor blockers (ARB) have emerged. Because the ACE2 (angiotensin-converting enzyme 2) enzyme is the receptor that allows SARS COV2 entry into cells, the fear was that pre-existing treatment with ACEi or ARB might increase the risk of developing severe or fatal severe acute respiratory syndrome in case of COVID-19 infection. The present article discusses these concerns. ACE2 is a membrane-bound enzyme (carboxypeptidase) that contributes to the inactivation of angiotensin II and therefore physiologically counters angiotensin II effects. ACEis do not inhibit ACE2. Although ARBs have been shown to upregulate ACE2 tissue expression in experimental animals, evidence was not always consistent in human studies. Moreover, to date there is no evidence that ACEi or ARB administration facilitates SARS COV2 cell entry by increasing ACE2 tissue expression in either animal or human studies. Finally, some studies support the hypothesis that elevated ACE2 membrane expression and tissue activity by administration of ARB and/or infusion of soluble ACE2 could confer protective properties against inflammatory tissue damage in COVID-19 infection. In summary, based on the currently available evidence and as advocated by many medical societies, ACEi or ARB should not be discontinued because of concerns with COVID-19 infection, except when the hemodynamic situation is precarious and case-by-case adjustment is required.
               
            ",Annales d'Endocrinologie,J Alexandre,"{'author': [{'$': 'J Alexandre'}, {'$': 'JL Cracowski'}, {'$': 'V Richard'}, {'$': 'B Bouhanick'}, {'$': 'in name of the “Drugs and COVID-19” working group of the French Society of Pharmacology and Therapeutics (SFPT)'}]}",https://api.elsevier.com/content/article/pii/S0003426620300627,10.1016/j.ando.2020.04.005,Private,S0003426620300627,"['Renin-angiotensin-aldosterone', 'system', 'COVID-19', 'infection']","['Abstract', 'With', 'multiplication', 'COVID-19', 'severe', 'acute', 'respiratory', 'syndrome', 'case', 'due', 'SARS', 'COV2,', 'concern', 'angiotensin-converting', 'enzyme', '1', '(ACE1)', 'inhibitors', '(ACEi)', 'angiotensin', 'II', 'type', '1', 'receptor', 'blockers', '(ARB)', 'emerged.', 'Because', 'ACE2', '(angiotensin-converting', 'enzyme', '2)', 'enzyme', 'receptor', 'allow', 'SARS', 'COV2', 'entry', 'cells,', 'fear', 'pre-existing', 'treatment', 'ACEi', 'ARB', 'might', 'increase', 'risk', 'develop', 'severe', 'fatal', 'severe', 'acute', 'respiratory', 'syndrome', 'case', 'COVID-19', 'infection.', 'The', 'present', 'article', 'discuss', 'concerns.', 'ACE2', 'membrane-bound', 'enzyme', '(carboxypeptidase)', 'contribute', 'inactivation', 'angiotensin', 'II', 'therefore', 'physiologically', 'counter', 'angiotensin', 'II', 'effects.', 'ACEis', 'inhibit', 'ACE2.', 'Although', 'ARBs', 'show', 'upregulate', 'ACE2', 'tissue', 'expression', 'experimental', 'animals,', 'evidence', 'always', 'consistent', 'human', 'studies.', 'Moreover,', 'date', 'evidence', 'ACEi', 'ARB', 'administration', 'facilitate', 'SARS', 'COV2', 'cell', 'entry', 'increase', 'ACE2', 'tissue', 'expression', 'either', 'animal', 'human', 'studies.', 'Finally,', 'study', 'support', 'hypothesis', 'elevate', 'ACE2', 'membrane', 'expression', 'tissue', 'activity', 'administration', 'ARB', 'and/or', 'infusion', 'soluble', 'ACE2', 'could', 'confer', 'protective', 'properties', 'inflammatory', 'tissue', 'damage', 'COVID-19', 'infection.', 'In', 'summary,', 'base', 'currently', 'available', 'evidence', 'advocate', 'many', 'medical', 'societies,', 'ACEi', 'ARB', 'discontinue', 'concern', 'COVID-19', 'infection,', 'except', 'hemodynamic', 'situation', 'precarious', 'case-by-case', 'adjustment', 'required.']"
DOI:10.1016/j.jamda.2020.04.017,2020-04-23T00:00:00.000Z,THE GERIATRICIAN: THE FRONTLINE SPECIALIST IN THE TREATMENT OF COVID-19 PATIENTS,"
               Abstract
               
                  On February 20, 2020, a man living in the north of Italy was admitted to the emergency room with an atypical pneumonia that later proved to be COVID-19. This was the trigger of one of the most serious clusters of COVID-19 in the world, outside of China. Despite aggressive restraint and inhibition efforts, COVID-19 continues to increase, and the total number of infected patients in Italy is growing daily. After six weeks the total number of patients reached 128,948 cases (April 5, 2020), with the higher case-fatality rate (15,887 deaths) dominated by old and very old patients.
                  This sudden health emergency severely challenged the Italian Health System, in particular acute care hospitals and intensive care units. In one hospital, geriatric observation units were created, the experience of which can be extremely useful for European countries, the United States, and all countries that in the coming days will face a similar situation.
               
            ",Journal of the American Medical Directors Association,Gemelli Against COVID-19 Geriatrics Team,"{'author': [{'$': 'Gemelli Against COVID-19 Geriatrics Team'}, {'$': 'F. Landi'}, {'$': 'C. Barillaro'}, {'$': 'A. Bellieni'}, {'$': 'R. Bernabei'}]}",https://api.elsevier.com/content/article/pii/S1525861020303479,10.1016/j.jamda.2020.04.017,Private,S1525861020303479,"['THE', 'GERIATRICIAN:', 'THE', 'FRONTLINE', 'SPECIALIST', 'IN', 'THE', 'TREATMENT', 'OF', 'COVID-19', 'PATIENTS']","['Abstract', 'On', 'February', '20,', '2020,', 'man', 'live', 'north', 'Italy', 'admit', 'emergency', 'room', 'atypical', 'pneumonia', 'later', 'prove', 'COVID-19.', 'This', 'trigger', 'one', 'serious', 'cluster', 'COVID-19', 'world,', 'outside', 'China.', 'Despite', 'aggressive', 'restraint', 'inhibition', 'efforts,', 'COVID-19', 'continue', 'increase,', 'total', 'number', 'infect', 'patients', 'Italy', 'grow', 'daily.', 'After', 'six', 'weeks', 'total', 'number', 'patients', 'reach', '128,948', 'case', '(April', '5,', '2020),', 'higher', 'case-fatality', 'rate', '(15,887', 'deaths)', 'dominate', 'old', 'old', 'patients.', 'This', 'sudden', 'health', 'emergency', 'severely', 'challenge', 'Italian', 'Health', 'System,', 'particular', 'acute', 'care', 'hospitals', 'intensive', 'care', 'units.', 'In', 'one', 'hospital,', 'geriatric', 'observation', 'units', 'created,', 'experience', 'extremely', 'useful', 'European', 'countries,', 'United', 'States,', 'countries', 'come', 'days', 'face', 'similar', 'situation.']"
DOI:10.1016/j.fertnstert.2020.04.025,2020-04-16T00:00:00.000Z,"Prior and Novel Coronaviruses, COVID-19, and Human Reproduction: What Is Known?","
               Structured Abstract
               
                  Objective
                  To summarize current understanding of the effects of novel and prior coronaviruses on human reproduction, specifically male and female gametes, and in pregnancy.
               
               
                  Design
                  Review of English publications in PubMed and Embase to April 6, 2020.
               
               
                  Methods
                  Manuscripts were screened for reports including coronavirus, reproduction, including pathophysiology and pregnancy.
               
               
                  Intervention(s)
                  None.
               
               
                  Main Outcome Measure(s)
                  Reproductive outcomes; effects on gametes; pregnancy outcomes; neonatal complications.
               
               
                  Results
                  Seventy-nine reports formed the basis of the review. Coronavirus binding to cells involves the S1 domain of the spike protein to receptors present in reproductive tissues, including angiotensin converting enzyme-2 (ACE2), CD26, Ezrin, and cyclophilins. SARS-CoV-1 may cause severe orchitis leading to germ cell destruction in males. Reports indicate decreased sperm concentration and motility for 72-90 days following COVID-19 infection. Gonadotropin-dependent expression of ACE2 was found in human ovaries, but it is unclear whether SARS-CoV-2 adversely affects female gametogenesis. Evidence suggests that COVID-19 infection has a lower maternal case fatality rate than SARS or MERS, but anecdotal reports suggest that infected, asymptomatic women may develop respiratory symptoms postpartum. COVID-19 infections in pregnancy are associated with preterm delivery. Postpartum neonatal transmission from mother to child has been reported.
               
               
                  Conclusion
                  COVID-19 infection may adversely affect some pregnant women and their offspring. Additional studies are needed to assess effects of SARS-CoV-2 infection on male and female fertility.
               
            ",Fertility and Sterility,James Segars,"{'author': [{'$': 'James Segars'}, {'$': 'Quinton Katler'}, {'$': 'Dana B. McQueen'}, {'$': 'Alexander Kotlyar'}, {'$': 'ASRM Coronavirus/COVID-19 Task Force'}]}",https://api.elsevier.com/content/article/pii/S001502822030385X,10.1016/j.fertnstert.2020.04.025,Private,S001502822030385X,"['Prior', 'Novel', 'Coronaviruses,', 'COVID-19,', 'Human', 'Reproduction:', 'What', 'Is', 'Known?']","['Structured', 'Abstract', 'Objective', 'To', 'summarize', 'current', 'understand', 'effect', 'novel', 'prior', 'coronaviruses', 'human', 'reproduction,', 'specifically', 'male', 'female', 'gametes,', 'pregnancy.', 'Design', 'Review', 'English', 'publications', 'PubMed', 'Embase', 'April', '6,', '2020.', 'Methods', 'Manuscripts', 'screen', 'report', 'include', 'coronavirus,', 'reproduction,', 'include', 'pathophysiology', 'pregnancy.', 'Intervention(s)', 'None.', 'Main', 'Outcome', 'Measure(s)', 'Reproductive', 'outcomes;', 'effect', 'gametes;', 'pregnancy', 'outcomes;', 'neonatal', 'complications.', 'Results', 'Seventy-nine', 'report', 'form', 'basis', 'review.', 'Coronavirus', 'bind', 'cells', 'involve', 'S1', 'domain', 'spike', 'protein', 'receptors', 'present', 'reproductive', 'tissues,', 'include', 'angiotensin', 'convert', 'enzyme-2', '(ACE2),', 'CD26,', 'Ezrin,', 'cyclophilins.', 'SARS-CoV-1', 'may', 'cause', 'severe', 'orchitis', 'lead', 'germ', 'cell', 'destruction', 'males.', 'Reports', 'indicate', 'decrease', 'sperm', 'concentration', 'motility', '72-90', 'days', 'follow', 'COVID-19', 'infection.', 'Gonadotropin-dependent', 'expression', 'ACE2', 'find', 'human', 'ovaries,', 'unclear', 'whether', 'SARS-CoV-2', 'adversely', 'affect', 'female', 'gametogenesis.', 'Evidence', 'suggest', 'COVID-19', 'infection', 'lower', 'maternal', 'case', 'fatality', 'rate', 'SARS', 'MERS,', 'anecdotal', 'report', 'suggest', 'infected,', 'asymptomatic', 'women', 'may', 'develop', 'respiratory', 'symptoms', 'postpartum.', 'COVID-19', 'infections', 'pregnancy', 'associate', 'preterm', 'delivery.', 'Postpartum', 'neonatal', 'transmission', 'mother', 'child', 'reported.', 'Conclusion', 'COVID-19', 'infection', 'may', 'adversely', 'affect', 'pregnant', 'women', 'offspring.', 'Additional', 'study', 'need', 'assess', 'effect', 'SARS-CoV-2', 'infection', 'male', 'female', 'fertility.']"
DOI:10.1016/j.neurol.2020.04.004,2020-04-20T00:00:00.000Z,Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network,"
               Abstract
               
                  In France, the epidemic phase of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in February 2020 and resulted in the implementation of emergency measures and a degradation in the organization of neuromuscular reference centers. In this special context, the French Rare Health Care for Neuromuscular Diseases Network (FILNEMUS) has established guidance in an attempt to homogenize the management of neuromuscular (NM) patients within the French territory. Hospitalization should be reserved for emergencies, the conduct of treatments that cannot be postponed, check-ups for which the diagnostic delay may result in a loss of survival chance, and cardiorespiratory assessments for which the delay could be detrimental to the patient. A national strategy was adopted during a period of 1 to 2months concerning treatments usually administered in hospitalization. NM patients treated with steroid/immunosuppressants for a dysimmune pathology should continue all of their treatments in the absence of any manifestations suggestive of COVID-19. A frequently asked questions (FAQ) sheet has been compiled and updated on the FILNEMUS website. Various support systems for self-rehabilitation and guided exercises have been also provided on the website. In the context of NM diseases, particular attention must be paid to two experimental COVID-19 treatments, hydroxycholoroquine and azithromycin: risk of exacerbation of myasthenia gravis and QT prolongation in patients with pre-existing cardiac involvement. The unfavorable emergency context related to COVID-19 may specially affect the potential for intensive care admission (ICU) for people with NMD. In order to preserve the fairest medical decision, a multidisciplinary working group has listed the neuromuscular diseases with a good prognosis, usually eligible for resuscitation admission in ICU and, for other NM conditions, the positive criteria suggesting a good prognosis. Adaptation of the use of noninvasive ventilation (NIV) make it possible to limit nebulization and continue using NIV in ventilator-dependent patients.
               
            ",Revue Neurologique,G. Solé,"{'author': [{'$': 'G. Solé'}, {'$': 'E. Salort-Campana'}, {'$': 'Y. Pereon'}, {'$': 'T. Stojkovic'}, {'$': 'FILNEMUS COVID-19 study group'}]}",https://api.elsevier.com/content/article/pii/S0035378720305233,10.1016/j.neurol.2020.04.004,Private,S0035378720305233,"['Guidance', 'care', 'neuromuscular', 'patients', 'COVID-19', 'pandemic', 'outbreak', 'French', 'Rare', 'Health', 'Care', 'Neuromuscular', 'Diseases', 'Network']","['Abstract', 'In', 'France,', 'epidemic', 'phase', 'COVID-19', 'cause', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '(SARS-CoV-2)', 'begin', 'February', '2020', 'result', 'implementation', 'emergency', 'measure', 'degradation', 'organization', 'neuromuscular', 'reference', 'centers.', 'In', 'special', 'context,', 'French', 'Rare', 'Health', 'Care', 'Neuromuscular', 'Diseases', 'Network', '(FILNEMUS)', 'establish', 'guidance', 'attempt', 'homogenize', 'management', 'neuromuscular', '(NM)', 'patients', 'within', 'French', 'territory.', 'Hospitalization', 'reserve', 'emergencies,', 'conduct', 'treatments', 'cannot', 'postponed,', 'check-ups', 'diagnostic', 'delay', 'may', 'result', 'loss', 'survival', 'chance,', 'cardiorespiratory', 'assessments', 'delay', 'could', 'detrimental', 'patient.', 'A', 'national', 'strategy', 'adopt', 'period', '1', '2months', 'concern', 'treatments', 'usually', 'administer', 'hospitalization.', 'NM', 'patients', 'treat', 'steroid/immunosuppressants', 'dysimmune', 'pathology', 'continue', 'treatments', 'absence', 'manifestations', 'suggestive', 'COVID-19.', 'A', 'frequently', 'ask', 'question', '(FAQ)', 'sheet', 'compile', 'update', 'FILNEMUS', 'website.', 'Various', 'support', 'systems', 'self-rehabilitation', 'guide', 'exercise', 'also', 'provide', 'website.', 'In', 'context', 'NM', 'diseases,', 'particular', 'attention', 'must', 'pay', 'two', 'experimental', 'COVID-19', 'treatments,', 'hydroxycholoroquine', 'azithromycin:', 'risk', 'exacerbation', 'myasthenia', 'gravis', 'QT', 'prolongation', 'patients', 'pre-existing', 'cardiac', 'involvement.', 'The', 'unfavorable', 'emergency', 'context', 'relate', 'COVID-19', 'may', 'specially', 'affect', 'potential', 'intensive', 'care', 'admission', '(ICU)', 'people', 'NMD.', 'In', 'order', 'preserve', 'fairest', 'medical', 'decision,', 'multidisciplinary', 'work', 'group', 'list', 'neuromuscular', 'diseases', 'good', 'prognosis,', 'usually', 'eligible', 'resuscitation', 'admission', 'ICU', 'and,', 'NM', 'conditions,', 'positive', 'criteria', 'suggest', 'good', 'prognosis.', 'Adaptation', 'use', 'noninvasive', 'ventilation', '(NIV)', 'make', 'possible', 'limit', 'nebulization', 'continue', 'use', 'NIV', 'ventilator-dependent', 'patients.']"
DOI:10.1016/j.jtcvs.2020.04.059,2020-04-27T00:00:00.000Z,Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery,"
               Abstract
               
                  The COVID-19 pandemic necessitates aggressive infection mitigation strategies to reduce the risk to patients and healthcare providers. This document is intended to provide a framework for the adult cardiac surgeon to consider in this rapidly changing environment. Pre, intra, and post-operative detailed protective measures are outlined. These are guidance recommendations during a pandemic surge to be utilized for ALL patients while local COVID-19 disease burden remains elevated.
               
            ",The Journal of Thoracic and Cardiovascular Surgery,Daniel T. Engelman,"{'author': [{'$': 'Daniel T. Engelman'}, {'$': 'Sylvain Lother'}, {'$': 'Isaac George'}, {'$': 'Duane J. Funk'}, {'$': 'Society of Thoracic Surgery COVID-19 Taskforce'}]}",https://api.elsevier.com/content/article/pii/S0022522320310114,10.1016/j.jtcvs.2020.04.059,Private,S0022522320310114,"['Adult', 'Cardiac', 'Surgery', 'COVID-19', 'Pandemic:', 'Aggressive', 'Infection', 'Mitigation', 'Strategies', 'Necessary', 'Operating', 'Room', 'Surgical', 'Recovery']","['Abstract', 'The', 'COVID-19', 'pandemic', 'necessitate', 'aggressive', 'infection', 'mitigation', 'strategies', 'reduce', 'risk', 'patients', 'healthcare', 'providers.', 'This', 'document', 'intend', 'provide', 'framework', 'adult', 'cardiac', 'surgeon', 'consider', 'rapidly', 'change', 'environment.', 'Pre,', 'intra,', 'post-operative', 'detail', 'protective', 'measure', 'outlined.', 'These', 'guidance', 'recommendations', 'pandemic', 'surge', 'utilize', 'ALL', 'patients', 'local', 'COVID-19', 'disease', 'burden', 'remain', 'elevated.']"
DOI:10.1016/j.athoracsur.2020.04.007,2020-04-27T00:00:00.000Z,Adult Cardiac Surgery and the COVID-19 Pandemic: Aggressive Infection Mitigation Strategies are Necessary in the Operating Room and Surgical Recovery,"
               Abstract
               
                  The COVID-19 pandemic necessitates aggressive infection mitigation strategies to reduce the risk to patients and healthcare providers. This document is intended to provide a framework for the adult cardiac surgeon to consider in this rapidly changing environment. Pre, intra, and post-operative detailed protective measures are outlined. These are guidance recommendations during a pandemic surge to be utilized for ALL patients while local COVID-19 disease burden remains elevated.
               
            ",The Annals of Thoracic Surgery,Daniel T. Engelman,"{'author': [{'$': 'Daniel T. Engelman'}, {'$': 'Sylvain Lother'}, {'$': 'Isaac George'}, {'$': 'Duane J. Funk'}, {'$': 'Society of Thoracic Surgery COVID-19 Taskforce'}]}",https://api.elsevier.com/content/article/pii/S0003497520305877,10.1016/j.athoracsur.2020.04.007,Private,S0003497520305877,"['Adult', 'Cardiac', 'Surgery', 'COVID-19', 'Pandemic:', 'Aggressive', 'Infection', 'Mitigation', 'Strategies', 'Necessary', 'Operating', 'Room', 'Surgical', 'Recovery']","['Abstract', 'The', 'COVID-19', 'pandemic', 'necessitate', 'aggressive', 'infection', 'mitigation', 'strategies', 'reduce', 'risk', 'patients', 'healthcare', 'providers.', 'This', 'document', 'intend', 'provide', 'framework', 'adult', 'cardiac', 'surgeon', 'consider', 'rapidly', 'change', 'environment.', 'Pre,', 'intra,', 'post-operative', 'detail', 'protective', 'measure', 'outlined.', 'These', 'guidance', 'recommendations', 'pandemic', 'surge', 'utilize', 'ALL', 'patients', 'local', 'COVID-19', 'disease', 'burden', 'remain', 'elevated.']"
DOI:10.1016/j.thromres.2020.04.024,2020-04-23T00:00:00.000Z,"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","
               Abstract
               
                  Background
                  Few data are available on the rate and characteristics of thromboembolic complications in hospitalized patients with COVID-19.
               
               
                  Methods
                  We studied consecutive symptomatic patients with laboratory-proven COVID-19 admitted to a university hospital in Milan, Italy (13.02.2020–10.04.2020). The primary outcome was any thromboembolic complication, including venous thromboembolism (VTE), ischemic stroke, and acute coronary syndrome (ACS)/myocardial infarction (MI). Secondary outcome was overt disseminated intravascular coagulation (DIC).
               
               
                  Results
                  We included 388 patients (median age 66 years, 68% men, 16% requiring intensive care [ICU]). Thromboprophylaxis was used in 100% of ICU patients and 75% of those on the general ward. Thromboembolic events occurred in 28 (7.7% of closed cases; 95%CI 5.4%–11.0%), corresponding to a cumulative rate of 21% (27.6% ICU, 6.6% general ward). Half of the thromboembolic events were diagnosed within 24 h of hospital admission. Forty-four patients underwent VTE imaging tests and VTE was confirmed in 16 (36%). Computed tomography pulmonary angiography (CTPA) was performed in 30 patients, corresponding to 7.7% of total, and pulmonary embolism was confirmed in 10 (33% of CTPA). The rate of ischemic stroke and ACS/MI was 2.5% and 1.1%, respectively. Overt DIC was present in 8 (2.2%) patients.
               
               
                  Conclusions
                  The high number of arterial and, in particular, venous thromboembolic events diagnosed within 24 h of admission and the high rate of positive VTE imaging tests among the few COVID-19 patients tested suggest that there is an urgent need to improve specific VTE diagnostic strategies and investigate the efficacy and safety of thromboprophylaxis in ambulatory COVID-19 patients.
               
            ",Thrombosis Research,Corrado Lodigiani,"{'author': [{'$': 'Corrado Lodigiani'}, {'$': 'Giacomo Iapichino'}, {'$': 'Luca Carenzo'}, {'$': 'Maurizio Cecconi'}, {'$': 'Humanitas COVID-19 Task Force'}]}",https://api.elsevier.com/content/article/pii/S0049384820301407,10.1016/j.thromres.2020.04.024,Private,S0049384820301407,"['Venous', 'arterial', 'thromboembolic', 'complications', 'COVID-19', 'patients', 'admit', 'academic', 'hospital', 'Milan,', 'Italy']","['Abstract', 'Background', 'Few', 'data', 'available', 'rate', 'characteristics', 'thromboembolic', 'complications', 'hospitalize', 'patients', 'COVID-19.', 'Methods', 'We', 'study', 'consecutive', 'symptomatic', 'patients', 'laboratory-proven', 'COVID-19', 'admit', 'university', 'hospital', 'Milan,', 'Italy', '(13.02.2020–10.04.2020).', 'The', 'primary', 'outcome', 'thromboembolic', 'complication,', 'include', 'venous', 'thromboembolism', '(VTE),', 'ischemic', 'stroke,', 'acute', 'coronary', 'syndrome', '(ACS)/myocardial', 'infarction', '(MI).', 'Secondary', 'outcome', 'overt', 'disseminate', 'intravascular', 'coagulation', '(DIC).', 'Results', 'We', 'include', '388', 'patients', '(median', 'age', '66', 'years,', '68%', 'men,', '16%', 'require', 'intensive', 'care', '[ICU]).', 'Thromboprophylaxis', 'use', '100%', 'ICU', 'patients', '75%', 'general', 'ward.', 'Thromboembolic', 'events', 'occur', '28', '(7.7%', 'close', 'cases;', '95%CI', '5.4%–11.0%),', 'correspond', 'cumulative', 'rate', '21%', '(27.6%', 'ICU,', '6.6%', 'general', 'ward).', 'Half', 'thromboembolic', 'events', 'diagnose', 'within', '24', 'h', 'hospital', 'admission.', 'Forty-four', 'patients', 'undergo', 'VTE', 'image', 'test', 'VTE', 'confirm', '16', '(36%).', 'Computed', 'tomography', 'pulmonary', 'angiography', '(CTPA)', 'perform', '30', 'patients,', 'correspond', '7.7%', 'total,', 'pulmonary', 'embolism', 'confirm', '10', '(33%', 'CTPA).', 'The', 'rate', 'ischemic', 'stroke', 'ACS/MI', '2.5%', '1.1%,', 'respectively.', 'Overt', 'DIC', 'present', '8', '(2.2%)', 'patients.', 'Conclusions', 'The', 'high', 'number', 'arterial', 'and,', 'particular,', 'venous', 'thromboembolic', 'events', 'diagnose', 'within', '24', 'h', 'admission', 'high', 'rate', 'positive', 'VTE', 'image', 'test', 'among', 'COVID-19', 'patients', 'test', 'suggest', 'urgent', 'need', 'improve', 'specific', 'VTE', 'diagnostic', 'strategies', 'investigate', 'efficacy', 'safety', 'thromboprophylaxis', 'ambulatory', 'COVID-19', 'patients.']"
DOI:10.1016/j.ekir.2020.04.001,2020-04-04T00:00:00.000Z,"Management of Patients on Dialysis and With Kidney Transplantation During the SARS-CoV-2 (COVID-19) Pandemic in Brescia, Italy","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease (COVID-19), is a major pandemic challenging health care systems around the world. The optimal management of patients infected with COVID-19 is still unclear, although the consensus is moving toward the need of a biphasic approach. During the first phase of the disease (from onset of the symptoms up to 7–10 days) viral-induced effects are prominent, with the opportunity to institute antiviral therapy. In the second inflammatory phase of the disease, immunosuppressive strategies (for example with glucocorticoids or anticytokine drugs) may be considered. This latter stage is characterized by the development of progressive lung involvement with increasing oxygen requirements and occasionally signs of the hemophagocytic syndrome. The management of the disease in patients with kidney disease is even more challenging, especially in those who are immunosuppressed or with severe comorbidities. Here we present the therapeutic approach used in Brescia (Italy) for managing patients infected with COVID-19 who underwent kidney transplantation and are receiving hemodialysis. Furthermore, we provide some clinical and physiopathological background, as well as preliminary outcome data of our cohort, to better clarify the pathogenesis of the disease and clinical management.",Kidney International Reports,Federico Alberici,"{'author': [{'$': 'Federico Alberici'}, {'$': 'Elisa Delbarba'}, {'$': 'Chiara Manenti'}, {'$': 'Laura Econimo'}, {'$': 'Brescia Renal COVID Task Force'}]}",https://api.elsevier.com/content/article/pii/S2468024920311700,10.1016/j.ekir.2020.04.001,Open,S2468024920311700,"['Management', 'Patients', 'Dialysis', 'With', 'Kidney', 'Transplantation', 'During', 'SARS-CoV-2', '(COVID-19)', 'Pandemic', 'Brescia,', 'Italy']","['The', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', '2', '(SARS-CoV-2),', 'also', 'know', 'coronavirus', 'disease', '(COVID-19),', 'major', 'pandemic', 'challenge', 'health', 'care', 'systems', 'around', 'world.', 'The', 'optimal', 'management', 'patients', 'infect', 'COVID-19', 'still', 'unclear,', 'although', 'consensus', 'move', 'toward', 'need', 'biphasic', 'approach.', 'During', 'first', 'phase', 'disease', '(from', 'onset', 'symptoms', '7–10', 'days)', 'viral-induced', 'effect', 'prominent,', 'opportunity', 'institute', 'antiviral', 'therapy.', 'In', 'second', 'inflammatory', 'phase', 'disease,', 'immunosuppressive', 'strategies', '(for', 'example', 'glucocorticoids', 'anticytokine', 'drugs)', 'may', 'considered.', 'This', 'latter', 'stage', 'characterize', 'development', 'progressive', 'lung', 'involvement', 'increase', 'oxygen', 'requirements', 'occasionally', 'sign', 'hemophagocytic', 'syndrome.', 'The', 'management', 'disease', 'patients', 'kidney', 'disease', 'even', 'challenging,', 'especially', 'immunosuppressed', 'severe', 'comorbidities.', 'Here', 'present', 'therapeutic', 'approach', 'use', 'Brescia', '(Italy)', 'manage', 'patients', 'infect', 'COVID-19', 'undergo', 'kidney', 'transplantation', 'receive', 'hemodialysis.', 'Furthermore,', 'provide', 'clinical', 'physiopathological', 'background,', 'well', 'preliminary', 'outcome', 'data', 'cohort,', 'better', 'clarify', 'pathogenesis', 'disease', 'clinical', 'management.']"
DOI:10.1016/j.jaci.2020.04.029,2020-04-29T00:00:00.000Z,Type I IFN immunoprofiling in COVID-19 patients,,Journal of Allergy and Clinical Immunology,Sophie Trouillet-Assant,"{'author': [{'$': 'Sophie Trouillet-Assant'}, {'$': 'Sebastien Viel'}, {'$': 'Alexandre Gaymard'}, {'$': 'Sylvie Pons'}, {'$': 'COVID HCL Study group'}]}",https://api.elsevier.com/content/article/pii/S0091674920305789,10.1016/j.jaci.2020.04.029,Open,S0091674920305789,"['Type', 'I', 'IFN', 'immunoprofiling', 'COVID-19', 'patients']",N/A
DOI:10.1016/j.therap.2020.04.004,2020-04-23T00:00:00.000Z,THERAP–COVID-19,"
               Summary
               
                  According to previous reports, diabetes seems to be associated with serious clinical events due to COVID-19. But is diabetes per se a risk factor of being infected by the virus? We discuss these points. Data about the antidiabetic drugs are scarce. Dipeptidylpeptidase-4 (DPP-4) is found as both a cell surface protein ubiquitously expressed in many tissues and as a soluble molecule found in serum/plasma, fluids. DPP-4 is involved in infection of cells by some viruses. We relate data about the use of DPP-4 inhibitors in diabetic patients. We conclude relating French and international recommendations in people with diabetes.
               
            ",Therapies,Béatrice Bouhanick,"{'author': [{'$': 'Béatrice Bouhanick'}, {'$': 'Jean-Luc Cracowski'}, {'$': 'Jean-Luc Faillie'}, {'$': 'au nom du groupe de travail “médicaments et COVID-19” de la “Société Française de Pharmacologie et Thérapeutique”'}]}",https://api.elsevier.com/content/article/pii/S0040595720300688,10.1016/j.therap.2020.04.004,Private,S0040595720300688,['THERAP–COVID-19'],"['Summary', 'According', 'previous', 'reports,', 'diabetes', 'seem', 'associate', 'serious', 'clinical', 'events', 'due', 'COVID-19.', 'But', 'diabetes', 'per', 'se', 'risk', 'factor', 'infect', 'virus?', 'We', 'discuss', 'points.', 'Data', 'antidiabetic', 'drug', 'scarce.', 'Dipeptidylpeptidase-4', '(DPP-4)', 'find', 'cell', 'surface', 'protein', 'ubiquitously', 'express', 'many', 'tissue', 'soluble', 'molecule', 'find', 'serum/plasma,', 'fluids.', 'DPP-4', 'involve', 'infection', 'cells', 'viruses.', 'We', 'relate', 'data', 'use', 'DPP-4', 'inhibitors', 'diabetic', 'patients.', 'We', 'conclude', 'relate', 'French', 'international', 'recommendations', 'people', 'diabetes.']"
DOI:10.1016/j.numecd.2020.04.001,2020-04-08T00:00:00.000Z,A close-up on COVID-19 and cardiovascular diseases,"
               Abstract
               
                  Aims
                  To analyze the potential mechanism of cardiovascular dysfunctions induced by Coronavirus Disease 2019 (COVID-19) and to evaluate more effective therapeutic pathways for patients with cardiovascular diseases.
               
               
                  Data Synthesis
                  COVID-19 mainly invades the lungs, causing its serious damage. Studies found that COVID-19 induced the renin-angiotensin system imbalance, inflammatory storm, hypoxemia and stress response et al, all contributed to hypertension and serious myocardial damage in the process of virus pathogenesis, even increasing mortality in COVID-19 patients.
               
               
                  Conclusions
                  In the process of management of COVID-19 infections, close attention should be paid on both lung and cardiovascular damage, especially on those with only symptoms of cardiovascular diseases. Early identification, timely and effective treatments, maintenance of hemodynamics and electrophysiological stability are of great significance on effective treatment and long-term prognosis.
                  The pandemic of COVID-19 has been taking lives worldwide. It caused by a novel coronavirus which human being are lack of defensive function in whole population. It targets human’s lung and causes serious damage of lungs. Based on early reports, for people with underlying heart issues, the concerns are serious. It appears people over 65 with coronary heart diseases or hypertension is more likely to be infected and to develop more severe symptoms. In addition, some of hospitalized COVID-19 patients had cardiovascular diseases in China. As characteristic analysis of COVID-19 patients, hypertension and severe myocardial damage contribute to severity [1] and mortality of COVID-19 patients [2]. Therefore, to better understand the development of COVID-19 and the impacts of cardiovascular diseases will add valuable measures to the management of COVID-19 patients.
               
            ","Nutrition, Metabolism and Cardiovascular Diseases",Gang Li,"{'author': [{'$': 'Gang Li'}, {'$': 'Rui Hu'}, {'$': 'Xuefang Gu'}]}",https://api.elsevier.com/content/article/pii/S0939475320301083,10.1016/j.numecd.2020.04.001,Private,S0939475320301083,"['A', 'close-up', 'COVID-19', 'cardiovascular', 'diseases']","['Abstract', 'Aims', 'To', 'analyze', 'potential', 'mechanism', 'cardiovascular', 'dysfunctions', 'induce', 'Coronavirus', 'Disease', '2019', '(COVID-19)', 'evaluate', 'effective', 'therapeutic', 'pathways', 'patients', 'cardiovascular', 'diseases.', 'Data', 'Synthesis', 'COVID-19', 'mainly', 'invade', 'lungs,', 'cause', 'serious', 'damage.', 'Studies', 'find', 'COVID-19', 'induce', 'renin-angiotensin', 'system', 'imbalance,', 'inflammatory', 'storm,', 'hypoxemia', 'stress', 'response', 'et', 'al,', 'contribute', 'hypertension', 'serious', 'myocardial', 'damage', 'process', 'virus', 'pathogenesis,', 'even', 'increase', 'mortality', 'COVID-19', 'patients.', 'Conclusions', 'In', 'process', 'management', 'COVID-19', 'infections,', 'close', 'attention', 'pay', 'lung', 'cardiovascular', 'damage,', 'especially', 'symptoms', 'cardiovascular', 'diseases.', 'Early', 'identification,', 'timely', 'effective', 'treatments,', 'maintenance', 'hemodynamics', 'electrophysiological', 'stability', 'great', 'significance', 'effective', 'treatment', 'long-term', 'prognosis.', 'The', 'pandemic', 'COVID-19', 'take', 'live', 'worldwide.', 'It', 'cause', 'novel', 'coronavirus', 'human', 'lack', 'defensive', 'function', 'whole', 'population.', 'It', 'target', 'human’s', 'lung', 'cause', 'serious', 'damage', 'lungs.', 'Based', 'early', 'reports,', 'people', 'underlie', 'heart', 'issues,', 'concern', 'serious.', 'It', 'appear', 'people', '65', 'coronary', 'heart', 'diseases', 'hypertension', 'likely', 'infect', 'develop', 'severe', 'symptoms.', 'In', 'addition,', 'hospitalize', 'COVID-19', 'patients', 'cardiovascular', 'diseases', 'China.', 'As', 'characteristic', 'analysis', 'COVID-19', 'patients,', 'hypertension', 'severe', 'myocardial', 'damage', 'contribute', 'severity', '[1]', 'mortality', 'COVID-19', 'patients', '[2].', 'Therefore,', 'better', 'understand', 'development', 'COVID-19', 'impact', 'cardiovascular', 'diseases', 'add', 'valuable', 'measure', 'management', 'COVID-19', 'patients.']"
DOI:10.1016/j.ijid.2020.04.061,2020-04-25T00:00:00.000Z,Mild versus severe COVID-19: laboratory markers,"Abstract The number of COVID-19 patients is increasing dramatically worldwide and treatment in intensive care units (ICU) has become a major challenge, the early recognition of severe forms of is absolutely essential for timely triaging of patients. While the clinical status, in particular Peripheral oxygen saturation (SpO2) levels and concurrent comorbidities of COVID-19 patients largely determines the need of their admittance to ICUs, several laboratory parameters may facilitate the assessment of disease severity. In hospitalized patients, clinicians should consider low lymphocyte count as well as the serum levels of CRP, D-dimers, ferritin and IL-6 which may be used in risk stratification to predict severe and fatal COVID-19. The more several or all of these parameters are altered, the more likely it is that the course of the disease will be unfavourable.",International Journal of Infectious Diseases,Thirumalaisamy P. Velavan,"{'author': [{'$': 'Thirumalaisamy P. Velavan'}, {'$': 'Christian G. Meyer'}]}",https://api.elsevier.com/content/article/pii/S1201971220302770,10.1016/j.ijid.2020.04.061,Open,S1201971220302770,"['Mild', 'versus', 'severe', 'COVID-19:', 'laboratory', 'markers']","['Abstract', 'The', 'number', 'COVID-19', 'patients', 'increase', 'dramatically', 'worldwide', 'treatment', 'intensive', 'care', 'units', '(ICU)', 'become', 'major', 'challenge,', 'early', 'recognition', 'severe', 'form', 'absolutely', 'essential', 'timely', 'triaging', 'patients.', 'While', 'clinical', 'status,', 'particular', 'Peripheral', 'oxygen', 'saturation', '(SpO2)', 'level', 'concurrent', 'comorbidities', 'COVID-19', 'patients', 'largely', 'determine', 'need', 'admittance', 'ICUs,', 'several', 'laboratory', 'parameters', 'may', 'facilitate', 'assessment', 'disease', 'severity.', 'In', 'hospitalize', 'patients,', 'clinicians', 'consider', 'low', 'lymphocyte', 'count', 'well', 'serum', 'level', 'CRP,', 'D-dimers,', 'ferritin', 'IL-6', 'may', 'use', 'risk', 'stratification', 'predict', 'severe', 'fatal', 'COVID-19.', 'The', 'several', 'parameters', 'altered,', 'likely', 'course', 'disease', 'unfavourable.']"
DOI:10.1016/j.jchirv.2020.04.009,2020-04-18T00:00:00.000Z,Gestion de l’épidémie de la COVID-19 par les établissements publics de santé — analyse de la Fédération hospitalière de France,"
               Résumé
               
                  Le but de cet article est de détailler les mesures prises dans les établissements publics pour faire face à l’épidémie de COVID-19. Sont détaillées la stratégie initiale, l’évolution organisationnelle vers le « tout-COVID », la coordination entre les différents intervenants ainsi que la stratégie de maintien de la continuité des soins. L’expérience au Québec est aussi prise en exemple. Enfin la sortie de crise doit être anticipée dès cette phase d’épidémie.
               
            
               Summary
               
                  The objective of this article is to detail the measures taken in public institutions to cope with the COVID-19 epidemic. It details the initial strategy, organizational evolution towards “all-COVID”, coordination between the various stakeholders and the strategy for maintaining continuity of care. The Quebec experience is also used as an example. Finally, an exit strategy must be anticipated at this phase of the epidemic.
               
            ",Journal de Chirurgie Viscérale,K. Barro,"{'author': [{'$': 'K. Barro'}, {'$': 'A. Malone'}, {'$': 'A. Mokede'}, {'$': 'C. Chevance'}]}",https://api.elsevier.com/content/article/pii/S1878786X20300966,10.1016/j.jchirv.2020.04.009,Private,S1878786X20300966,"['Gestion', 'de', 'l’épidémie', 'de', 'la', 'COVID-19', 'par', 'les', 'établissements', 'publics', 'de', 'santé', '—', 'analyse', 'de', 'la', 'Fédération', 'hospitalière', 'de', 'France']","['Résumé', 'Le', 'de', 'cet', 'article', 'est', 'de', 'détailler', 'les', 'mesures', 'prise', 'dans', 'les', 'établissements', 'publics', 'pour', 'faire', 'face', 'à', 'l’épidémie', 'de', 'COVID-19.', 'Sont', 'détaillées', 'la', 'stratégie', 'initiale,', 'l’évolution', 'organisationnelle', 'vers', 'le', '«', 'tout-COVID', '»,', 'la', 'coordination', 'entre', 'les', 'différents', 'intervenants', 'ainsi', 'que', 'la', 'stratégie', 'de', 'maintien', 'de', 'la', 'continuité', 'des', 'soins.', 'L’expérience', 'au', 'Québec', 'est', 'aussi', 'prise', 'en', 'exemple.', 'Enfin', 'la', 'sortie', 'de', 'crise', 'doit', 'être', 'anticipée', 'dès', 'cette', 'phase', 'd’épidémie.', 'Summary', 'The', 'objective', 'article', 'detail', 'measure', 'take', 'public', 'institutions', 'cope', 'COVID-19', 'epidemic.', 'It', 'detail', 'initial', 'strategy,', 'organizational', 'evolution', 'towards', '“all-COVID”,', 'coordination', 'various', 'stakeholders', 'strategy', 'maintain', 'continuity', 'care.', 'The', 'Quebec', 'experience', 'also', 'use', 'example.', 'Finally,', 'exit', 'strategy', 'must', 'anticipate', 'phase', 'epidemic.']"
DOI:10.1016/j.medmal.2020.04.006,2020-04-17T00:00:00.000Z,Features of anosmia in COVID-19,"
               Abstract
               
                  Background
                  Medical publications about anosmia with COVID-19 are scarce. We aimed to describe the prevalence and features of anosmia in COVID-19 patients.
               
               
                  Methods
                  We retrospectively included COVID-19 patients with anosmia between March 1st and March 17th, 2020. We used SARS-CoV-2 real time PCR in respiratory samples to confirm the cases.
               
               
                  Results
                  Fifty-four of 114 patients (47%) with confirmed COVID-19 reported anosmia. Mean age of the 54 patients was 47 (±16) years; 67% were females and 37% were hospitalised. The median Charlson comorbidity index was 0.70 (±1.6 [0–7]). Forty-six patients (85%) had dysgeusia and 28% presented with pneumonia. Anosmia began 4.4 (±1.9 [1–8]) days after infection onset. The mean duration of anosmia was 8.9 (±6.3 [1–21]) days and 98% of patients recovered within 28 days.
               
               
                  Conclusions
                  Anosmia was present in half of our European COVID-19 patients and was often associated with dysgeusia.
               
            ",Médecine et Maladies Infectieuses,T. Klopfenstein,"{'author': [{'$': 'T. Klopfenstein'}, {'$': 'N. J. Kadiane-Oussou'}, {'$': 'L. Toko'}, {'$': 'P. -Y. Royer'}, {'$': 'S. Zayet'}]}",https://api.elsevier.com/content/article/pii/S0399077X20301104,10.1016/j.medmal.2020.04.006,Private,S0399077X20301104,"['Features', 'anosmia', 'COVID-19']","['Abstract', 'Background', 'Medical', 'publications', 'anosmia', 'COVID-19', 'scarce.', 'We', 'aim', 'describe', 'prevalence', 'feature', 'anosmia', 'COVID-19', 'patients.', 'Methods', 'We', 'retrospectively', 'include', 'COVID-19', 'patients', 'anosmia', 'March', '1st', 'March', '17th,', '2020.', 'We', 'use', 'SARS-CoV-2', 'real', 'time', 'PCR', 'respiratory', 'sample', 'confirm', 'cases.', 'Results', 'Fifty-four', '114', 'patients', '(47%)', 'confirm', 'COVID-19', 'report', 'anosmia.', 'Mean', 'age', '54', 'patients', '47', '(±16)', 'years;', '67%', 'females', '37%', 'hospitalised.', 'The', 'median', 'Charlson', 'comorbidity', 'index', '0.70', '(±1.6', '[0–7]).', 'Forty-six', 'patients', '(85%)', 'dysgeusia', '28%', 'present', 'pneumonia.', 'Anosmia', 'begin', '4.4', '(±1.9', '[1–8])', 'days', 'infection', 'onset.', 'The', 'mean', 'duration', 'anosmia', '8.9', '(±6.3', '[1–21])', 'days', '98%', 'patients', 'recover', 'within', '28', 'days.', 'Conclusions', 'Anosmia', 'present', 'half', 'European', 'COVID-19', 'patients', 'often', 'associate', 'dysgeusia.']"
DOI:10.1016/j.bbi.2020.04.077,2020-04-28T00:00:00.000Z,COVID-19 presenting as stroke,"
               Abstract
               
                  Objective
                  Acute stroke remains a medical emergency even during the COVID-19 pandemic. Most patients with COVID-19 present with constitutional and respiratory symptoms, some patients present with atypical symptoms including gastrointestinal, cardiovascular, or neurological symptoms. Here we present a series of four COVID-19 patients with acute stroke as a presenting symptom.
               
               
                  Methods
                  We searched the hospital databases for patients presenting with acute strokes and suspected COVID-19 features. All patients that had imaging confirmed strokes and PCR confirmed COVID-19 were included in the study. Patients admitted to the hospital with PCR confirmed COVID-19 disease whose hospital course was complicated with acute stroke while inpatient were excluded from the study. Retrospective patient data were obtained from electronic medical records. Informed consent was obtained.
               
               
                  Results
                  We identified four patients presenting with imaging confirmed acute strokes and PCR confirmed SARS-CoV-2 infection. We elucidate the clinical characteristics, imaging findings, and the clinical course.
               
               
                  Conclusions
                  Timely assessment and hyperacute treatment is the key to minimize mortality and morbidity of patients with acute stroke. Stroke teams should be wary of the fact that COVID-19 patients can present with cerebrovascular accidents and dawn appropriate personal protective equipment in every suspected patient. Further studies are urgently needed for a comprehensive understanding of the neurological pathology of COVID-19 and its effects on the nervous system.
               
            ","Brain, Behavior, and Immunity",Akshay Avula,"{'author': [{'$': 'Akshay Avula'}, {'$': 'Krishna Nalleballe'}, {'$': 'Naureen Narula'}, {'$': 'Steven Sapozhnikov'}, {'$': 'Dany Elsayegh'}]}",https://api.elsevier.com/content/article/pii/S0889159120306851,10.1016/j.bbi.2020.04.077,Private,S0889159120306851,"['COVID-19', 'present', 'stroke']","['Abstract', 'Objective', 'Acute', 'stroke', 'remain', 'medical', 'emergency', 'even', 'COVID-19', 'pandemic.', 'Most', 'patients', 'COVID-19', 'present', 'constitutional', 'respiratory', 'symptoms,', 'patients', 'present', 'atypical', 'symptoms', 'include', 'gastrointestinal,', 'cardiovascular,', 'neurological', 'symptoms.', 'Here', 'present', 'series', 'four', 'COVID-19', 'patients', 'acute', 'stroke', 'present', 'symptom.', 'Methods', 'We', 'search', 'hospital', 'databases', 'patients', 'present', 'acute', 'stroke', 'suspect', 'COVID-19', 'features.', 'All', 'patients', 'image', 'confirm', 'stroke', 'PCR', 'confirm', 'COVID-19', 'include', 'study.', 'Patients', 'admit', 'hospital', 'PCR', 'confirm', 'COVID-19', 'disease', 'whose', 'hospital', 'course', 'complicate', 'acute', 'stroke', 'inpatient', 'exclude', 'study.', 'Retrospective', 'patient', 'data', 'obtain', 'electronic', 'medical', 'records.', 'Informed', 'consent', 'obtained.', 'Results', 'We', 'identify', 'four', 'patients', 'present', 'image', 'confirm', 'acute', 'stroke', 'PCR', 'confirm', 'SARS-CoV-2', 'infection.', 'We', 'elucidate', 'clinical', 'characteristics,', 'image', 'findings,', 'clinical', 'course.', 'Conclusions', 'Timely', 'assessment', 'hyperacute', 'treatment', 'key', 'minimize', 'mortality', 'morbidity', 'patients', 'acute', 'stroke.', 'Stroke', 'team', 'wary', 'fact', 'COVID-19', 'patients', 'present', 'cerebrovascular', 'accidents', 'dawn', 'appropriate', 'personal', 'protective', 'equipment', 'every', 'suspect', 'patient.', 'Further', 'study', 'urgently', 'need', 'comprehensive', 'understand', 'neurological', 'pathology', 'COVID-19', 'effect', 'nervous', 'system.']"
DOI:10.1016/j.dsx.2020.03.011,2020-03-26T00:00:00.000Z,Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries,"
               Abstract
               
                  Background and aims
                  No drugs are currently approved for Coronavirus Disease-2019 (COVID-19), although some have been tried. In view of recent studies and discussion on chloroquine and hydroxychloroquine (HCQ), we aimed to review existing literature and relevant websites regarding these drugs and COVID-19, adverse effects related to drugs, and related guidelines.
               
               
                  Aims and methods
                  We systematically searched the PubMed database up till March 21, 2020 and retrieved all the articles published on chloroquine and HCQ and COVID-19.
               
               
                  Results
                  Two small human studies have been conducted with both these drugs in COVID-19, and have shown significant improvement in some parameters in patients with COVID-19.
               
               
                  Conclusion
                  Considering minimal risk upon use, a long experience of use in other diseases, cost-effectiveness and easy availability across India, we propose that both these drugs are worthy of fast track clinical trial for treatment, and may be carefully considered for clinical use as experimental drugs. Since HCQ has been approved for treatment of diabetes in India, it should be further researched in diabetes and COVID-19, a subgroup where significant mortality has been shown.
               
            ",Diabetes & Metabolic Syndrome: Clinical Research & Reviews,Awadhesh Kumar Singh,"{'author': [{'$': 'Awadhesh Kumar Singh'}, {'$': 'Akriti Singh'}, {'$': 'Altamash Shaikh'}, {'$': 'Ritu Singh'}, {'$': 'Anoop Misra'}]}",https://api.elsevier.com/content/article/pii/S1871402120300515,10.1016/j.dsx.2020.03.011,Private,S1871402120300515,"['Chloroquine', 'hydroxychloroquine', 'treatment', 'COVID-19', 'without', 'diabetes:', 'A', 'systematic', 'search', 'narrative', 'review', 'special', 'reference', 'India', 'develop', 'countries']","['Abstract', 'Background', 'aim', 'No', 'drug', 'currently', 'approve', 'Coronavirus', 'Disease-2019', '(COVID-19),', 'although', 'tried.', 'In', 'view', 'recent', 'study', 'discussion', 'chloroquine', 'hydroxychloroquine', '(HCQ),', 'aim', 'review', 'exist', 'literature', 'relevant', 'websites', 'regard', 'drug', 'COVID-19,', 'adverse', 'effect', 'relate', 'drugs,', 'relate', 'guidelines.', 'Aims', 'methods', 'We', 'systematically', 'search', 'PubMed', 'database', 'till', 'March', '21,', '2020', 'retrieve', 'article', 'publish', 'chloroquine', 'HCQ', 'COVID-19.', 'Results', 'Two', 'small', 'human', 'study', 'conduct', 'drug', 'COVID-19,', 'show', 'significant', 'improvement', 'parameters', 'patients', 'COVID-19.', 'Conclusion', 'Considering', 'minimal', 'risk', 'upon', 'use,', 'long', 'experience', 'use', 'diseases,', 'cost-effectiveness', 'easy', 'availability', 'across', 'India,', 'propose', 'drug', 'worthy', 'fast', 'track', 'clinical', 'trial', 'treatment,', 'may', 'carefully', 'consider', 'clinical', 'use', 'experimental', 'drugs.', 'Since', 'HCQ', 'approve', 'treatment', 'diabetes', 'India,', 'research', 'diabetes', 'COVID-19,', 'subgroup', 'significant', 'mortality', 'shown.']"
DOI:10.1016/j.scitotenv.2020.139051,2020-04-28T00:00:00.000Z,Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries,"Abstract The coronavirus disease 2019 (COVID-19) pandemic is the defining global health crisis of our time and the greatest challenge facing the world. Meteorological parameters are reportedly crucial factors affecting respiratory infectious disease epidemics; however, the effect of meteorological parameters on COVID-19 remains controversial. This study investigated the effects of temperature and relative humidity on daily new cases and daily new deaths of COVID-19, which has useful implications for policymakers and the public. Daily data on meteorological conditions, new cases and new deaths of COVID-19 were collected for 166 countries (excluding China) as of March 27, 2020. Log-linear generalized additive model was used to analyze the effects of temperature and relative humidity on daily new cases and daily new deaths of COVID-19, with potential confounders controlled for, including wind speed, median age of the national population, Global Health Security Index, Human Development Index and population density. Our findings revealed that temperature and relative humidity were both negatively related to daily new cases and deaths. A 1 °C increase in temperature was associated with a 3.08% (95% CI: 1.53%, 4.63%) reduction in daily new cases and a 1.19% (95% CI: 0.44%, 1.95%) reduction in daily new deaths, whereas a 1% increase in relative humidity was associated with a 0.85% (95% CI: 0.51%, 1.19%) reduction in daily new cases and a 0.51% (95% CI: 0.34%, 0.67%) reduction in daily new deaths. The results remained robust when different lag structures and the sensitivity analysis were used. These findings provide preliminary evidence that the COVID-19 pandemic may be partially suppressed with temperature and humidity increases. However, active measures must be taken to control the source of infection, block transmission and prevent further spread of COVID-19.",Science of The Total Environment,Yu Wu,"{'author': [{'$': 'Yu Wu'}, {'$': 'Wenzhan Jing'}, {'$': 'Jue Liu'}, {'$': 'Qiuyue Ma'}, {'$': 'Min Liu'}]}",https://api.elsevier.com/content/article/pii/S0048969720325687,10.1016/j.scitotenv.2020.139051,Open,S0048969720325687,"['Effects', 'temperature', 'humidity', 'daily', 'new', 'case', 'new', 'deaths', 'COVID-19', '166', 'countries']","['Abstract', 'The', 'coronavirus', 'disease', '2019', '(COVID-19)', 'pandemic', 'define', 'global', 'health', 'crisis', 'time', 'greatest', 'challenge', 'face', 'world.', 'Meteorological', 'parameters', 'reportedly', 'crucial', 'factor', 'affect', 'respiratory', 'infectious', 'disease', 'epidemics;', 'however,', 'effect', 'meteorological', 'parameters', 'COVID-19', 'remain', 'controversial.', 'This', 'study', 'investigate', 'effect', 'temperature', 'relative', 'humidity', 'daily', 'new', 'case', 'daily', 'new', 'deaths', 'COVID-19,', 'useful', 'implications', 'policymakers', 'public.', 'Daily', 'data', 'meteorological', 'conditions,', 'new', 'case', 'new', 'deaths', 'COVID-19', 'collect', '166', 'countries', '(excluding', 'China)', 'March', '27,', '2020.', 'Log-linear', 'generalize', 'additive', 'model', 'use', 'analyze', 'effect', 'temperature', 'relative', 'humidity', 'daily', 'new', 'case', 'daily', 'new', 'deaths', 'COVID-19,', 'potential', 'confounders', 'control', 'for,', 'include', 'wind', 'speed,', 'median', 'age', 'national', 'population,', 'Global', 'Health', 'Security', 'Index,', 'Human', 'Development', 'Index', 'population', 'density.', 'Our', 'find', 'reveal', 'temperature', 'relative', 'humidity', 'negatively', 'relate', 'daily', 'new', 'case', 'deaths.', 'A', '1', '°C', 'increase', 'temperature', 'associate', '3.08%', '(95%', 'CI:', '1.53%,', '4.63%)', 'reduction', 'daily', 'new', 'case', '1.19%', '(95%', 'CI:', '0.44%,', '1.95%)', 'reduction', 'daily', 'new', 'deaths,', 'whereas', '1%', 'increase', 'relative', 'humidity', 'associate', '0.85%', '(95%', 'CI:', '0.51%,', '1.19%)', 'reduction', 'daily', 'new', 'case', '0.51%', '(95%', 'CI:', '0.34%,', '0.67%)', 'reduction', 'daily', 'new', 'deaths.', 'The', 'result', 'remain', 'robust', 'different', 'lag', 'structure', 'sensitivity', 'analysis', 'used.', 'These', 'find', 'provide', 'preliminary', 'evidence', 'COVID-19', 'pandemic', 'may', 'partially', 'suppress', 'temperature', 'humidity', 'increases.', 'However,', 'active', 'measure', 'must', 'take', 'control', 'source', 'infection,', 'block', 'transmission', 'prevent', 'spread', 'COVID-19.']"
DOI:10.1016/j.scitotenv.2020.138890,2020-04-23T00:00:00.000Z,Impact of temperature on the dynamics of the COVID-19 outbreak in China,"
               Abstract
               
                  A COVID-19 outbreak emerged in Wuhan, China at the end of 2019 and developed into a global pandemic during March 2020. The effects of temperature on the dynamics of the COVID-19 epidemic in China are unknown. Data on COVID-19 daily confirmed cases and daily mean temperatures were collected from 31 provincial-level regions in mainland China between Jan. 20 and Feb. 29, 2020. Locally weighted regression and smoothing scatterplot (LOESS), distributed lag nonlinear models (DLNMs), and random-effects meta-analysis were used to examine the relationship between daily confirmed cases rate of COVID-19 and temperature conditions. The daily number of new cases peaked on Feb. 12, and then decreased. The daily confirmed cases rate of COVID-19 had a biphasic relationship with temperature (with a peak at 10 °C), and the daily incidence of COVID-19 decreased at values below and above these values. The overall epidemic intensity of COVID-19 reduced slightly following days with higher temperatures with a relative risk (RR) was 0.96 (95% CI: 0.93, 0.99). A random-effect meta-analysis including 28 provinces in mainland China, we confirmed the statistically significant association between temperature and RR during the study period (Coefficient = −0.0100, 95% CI: −0.0125, −0.0074). The DLNMs in Hubei Province (outside of Wuhan) and Wuhan showed similar patterns of temperature. Additionally, a modified susceptible-exposed-infectious-recovered (M-SEIR) model, with adjustment for climatic factors, was used to provide a complete characterization of the impact of climate on the dynamics of the COVID-19 epidemic.
               
            ",Science of The Total Environment,Peng Shi,"{'author': [{'$': 'Peng Shi'}, {'$': 'Yinqiao Dong'}, {'$': 'Huanchang Yan'}, {'$': 'Chenkai Zhao'}, {'$': 'Shuhua Xi'}]}",https://api.elsevier.com/content/article/pii/S0048969720324074,10.1016/j.scitotenv.2020.138890,Private,S0048969720324074,"['Impact', 'temperature', 'dynamics', 'COVID-19', 'outbreak', 'China']","['Abstract', 'A', 'COVID-19', 'outbreak', 'emerge', 'Wuhan,', 'China', 'end', '2019', 'develop', 'global', 'pandemic', 'March', '2020.', 'The', 'effect', 'temperature', 'dynamics', 'COVID-19', 'epidemic', 'China', 'unknown.', 'Data', 'COVID-19', 'daily', 'confirm', 'case', 'daily', 'mean', 'temperatures', 'collect', '31', 'provincial-level', 'regions', 'mainland', 'China', 'Jan.', '20', 'Feb.', '29,', '2020.', 'Locally', 'weight', 'regression', 'smooth', 'scatterplot', '(LOESS),', 'distribute', 'lag', 'nonlinear', 'model', '(DLNMs),', 'random-effects', 'meta-analysis', 'use', 'examine', 'relationship', 'daily', 'confirm', 'case', 'rate', 'COVID-19', 'temperature', 'conditions.', 'The', 'daily', 'number', 'new', 'case', 'peak', 'Feb.', '12,', 'decreased.', 'The', 'daily', 'confirm', 'case', 'rate', 'COVID-19', 'biphasic', 'relationship', 'temperature', '(with', 'peak', '10', '°C),', 'daily', 'incidence', 'COVID-19', 'decrease', 'value', 'values.', 'The', 'overall', 'epidemic', 'intensity', 'COVID-19', 'reduce', 'slightly', 'follow', 'days', 'higher', 'temperatures', 'relative', 'risk', '(RR)', '0.96', '(95%', 'CI:', '0.93,', '0.99).', 'A', 'random-effect', 'meta-analysis', 'include', '28', 'provinces', 'mainland', 'China,', 'confirm', 'statistically', 'significant', 'association', 'temperature', 'RR', 'study', 'period', '(Coefficient', '=', '−0.0100,', '95%', 'CI:', '−0.0125,', '−0.0074).', 'The', 'DLNMs', 'Hubei', 'Province', '(outside', 'Wuhan)', 'Wuhan', 'show', 'similar', 'pattern', 'temperature.', 'Additionally,', 'modify', 'susceptible-exposed-infectious-recovered', '(M-SEIR)', 'model,', 'adjustment', 'climatic', 'factors,', 'use', 'provide', 'complete', 'characterization', 'impact', 'climate', 'dynamics', 'COVID-19', 'epidemic.']"
DOI:10.1016/j.envres.2020.109586,2020-04-24T00:00:00.000Z,Biomass use and COVID-19: A novel concern,"Abstract Evidence supports the link between air pollution and COVID-19 and thus it is likely that exposure to biomass smoke is associated with COVID-19. The poor, including refugees and migrant workers staying in fragile conditions, are most vulnerable. An outbreak of COVID-19 in a place where the concept of physical distancing is next to impossible could easily overwhelm the public health system. It is thus essential to understand the consequences of being exposed to smoke in relation to COVID-19 infection.",Environmental Research,Megha Thakur,"{'author': [{'$': 'Megha Thakur'}, {'$': 'Esther A. Boudewijns'}, {'$': 'Giridhara R. Babu'}, {'$': 'Onno C. P. van Schayck'}]}",https://api.elsevier.com/content/article/pii/S0013935120304795,10.1016/j.envres.2020.109586,Open,S0013935120304795,"['Biomass', 'use', 'COVID-19:', 'A', 'novel', 'concern']","['Abstract', 'Evidence', 'support', 'link', 'air', 'pollution', 'COVID-19', 'thus', 'likely', 'exposure', 'biomass', 'smoke', 'associate', 'COVID-19.', 'The', 'poor,', 'include', 'refugees', 'migrant', 'workers', 'stay', 'fragile', 'conditions,', 'vulnerable.', 'An', 'outbreak', 'COVID-19', 'place', 'concept', 'physical', 'distance', 'next', 'impossible', 'could', 'easily', 'overwhelm', 'public', 'health', 'system.', 'It', 'thus', 'essential', 'understand', 'consequences', 'expose', 'smoke', 'relation', 'COVID-19', 'infection.']"
DOI:10.1016/j.jcv.2020.104379,2020-04-22T00:00:00.000Z,COVID-19 in Vietnam: a lesson of pre-preparation,"
               Abstract
               
                  Background
                  Vietnam was slowing the spread of COVID-19 to 200 cases by the end of March. From perspective of a relatively vulnerable healthcare systems, timely interventions were implemented to different stage of pandemic progress to limit the spread.
               
               
                  Method
                  The authors compiled literature on different public health measures in Vietnam in compared to the progression of COVID-19 from January to March 2020.
               
               
                  Results
                  Three stages of pandemic progression of COVID-19 were recorded in Vietnam. At 213 confirmed cases under treatment and isolation, a range of interventions were enforced including intensive and expansive contact, mass testing, isolation, and sterilization. Many were in place before any case were reported.
               
               
                  Conclusion
                  Preparation were key for Vietnam's healthcare system in the ever-changing landscape of COVID-19 pandemic.
               
            ",Journal of Clinical Virology,Ha-Linh Quach,"{'author': [{'$': 'Ha-Linh Quach'}, {'$': 'Ngoc-Anh Hoang Thi'}]}",https://api.elsevier.com/content/article/pii/S1386653220301219,10.1016/j.jcv.2020.104379,Private,S1386653220301219,"['COVID-19', 'Vietnam:', 'lesson', 'pre-preparation']","['Abstract', 'Background', 'Vietnam', 'slow', 'spread', 'COVID-19', '200', 'case', 'end', 'March.', 'From', 'perspective', 'relatively', 'vulnerable', 'healthcare', 'systems,', 'timely', 'interventions', 'implement', 'different', 'stage', 'pandemic', 'progress', 'limit', 'spread.', 'Method', 'The', 'author', 'compile', 'literature', 'different', 'public', 'health', 'measure', 'Vietnam', 'compare', 'progression', 'COVID-19', 'January', 'March', '2020.', 'Results', 'Three', 'stag', 'pandemic', 'progression', 'COVID-19', 'record', 'Vietnam.', 'At', '213', 'confirm', 'case', 'treatment', 'isolation,', 'range', 'interventions', 'enforce', 'include', 'intensive', 'expansive', 'contact,', 'mass', 'testing,', 'isolation,', 'sterilization.', 'Many', 'place', 'case', 'reported.', 'Conclusion', 'Preparation', 'key', ""Vietnam's"", 'healthcare', 'system', 'ever-changing', 'landscape', 'COVID-19', 'pandemic.']"
DOI:10.1016/j.athoracsur.2020.03.005,2020-04-09T00:00:00.000Z,COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement from Thoracic Surgery Outcomes Research Network,"
               Abstract
               
                  The extraordinary demands of managing the COVID-19 pandemic has disrupted the world’s ability to care for patients with thoracic malignancies. As a hospital’s COVID-19 population increases and hospital resources are depleted, the ability to provide surgical care is progressively restricted - forcing surgeons to prioritize among their cancer populations. Representatives from multiple cancer, surgical and research organizations have come together to provide a guide for triaging patients with thoracic malignancies, as the impact of COVID-19 evolves as each hospital.
               
            ",The Annals of Thoracic Surgery,"Thoracic Surgery Outcomes Research Network, Inc","{'author': 'Thoracic Surgery Outcomes Research Network, Inc'}",https://api.elsevier.com/content/article/pii/S0003497520304422,10.1016/j.athoracsur.2020.03.005,Private,S0003497520304422,"['COVID-19', 'Guidance', 'Triage', 'Operations', 'Thoracic', 'Malignancies:', 'A', 'Consensus', 'Statement', 'Thoracic', 'Surgery', 'Outcomes', 'Research', 'Network']","['Abstract', 'The', 'extraordinary', 'demand', 'manage', 'COVID-19', 'pandemic', 'disrupt', 'world’s', 'ability', 'care', 'patients', 'thoracic', 'malignancies.', 'As', 'hospital’s', 'COVID-19', 'population', 'increase', 'hospital', 'resources', 'depleted,', 'ability', 'provide', 'surgical', 'care', 'progressively', 'restrict', '-', 'force', 'surgeons', 'prioritize', 'among', 'cancer', 'populations.', 'Representatives', 'multiple', 'cancer,', 'surgical', 'research', 'organizations', 'come', 'together', 'provide', 'guide', 'triaging', 'patients', 'thoracic', 'malignancies,', 'impact', 'COVID-19', 'evolve', 'hospital.']"
DOI:10.1016/j.bbih.2020.100064,2020-03-29T00:00:00.000Z,Knowledge and attitudes of medical staff in Chinese psychiatric hospitals regarding COVID-19,"Abstract On March 11, 2020, the World Health Organization (WHO) declared the novel coronavirus COVID-19 a pandemic. There are patients in psychiatric hospitals in China who have been infected with COVID-19, however, the knowledge and attitudes of psychiatric hospital staff towards infectious diseases and their willingness to work during the COVID-19 outbreak has not yet been investigated. This study was performed to assess the knowledge and attitudes of medical staff in two Chinese mental health centers during the COVID-19 outbreak. We included 141 psychiatrists and 170 psychiatric nurses in the study. We found that during the COVID-19 epidemic, 89.51% of the medical staff of the psychiatric hospitals studied had extensive knowledge of COVID-19, and 64.63% of them received the relevant training in hospitals. Furthermore, about 77.17% of participants expressed a willingness to care for psychiatric patients suffering from COVID-19 virus infection. Independent predictors of willingness to care for patients included advanced training and experience of caring for patients with COVID-19. In conclusion, this study suggests that increased attention should be paid to the knowledge and attitudes of medical staff at psychiatric hospitals during the COVID-19 outbreak.","Brain, Behavior, & Immunity - Health",Yudong Shi,"{'author': [{'$': 'Yudong Shi'}, {'$': 'Juan Wang'}, {'$': 'Yating Yang'}, {'$': 'Zhiqiang Wang'}, {'$': 'Huanzhong Liu'}]}",https://api.elsevier.com/content/article/pii/S2666354620300296,10.1016/j.bbih.2020.100064,Open,S2666354620300296,"['Knowledge', 'attitudes', 'medical', 'staff', 'Chinese', 'psychiatric', 'hospitals', 'regard', 'COVID-19']","['Abstract', 'On', 'March', '11,', '2020,', 'World', 'Health', 'Organization', '(WHO)', 'declare', 'novel', 'coronavirus', 'COVID-19', 'pandemic.', 'There', 'patients', 'psychiatric', 'hospitals', 'China', 'infect', 'COVID-19,', 'however,', 'knowledge', 'attitudes', 'psychiatric', 'hospital', 'staff', 'towards', 'infectious', 'diseases', 'willingness', 'work', 'COVID-19', 'outbreak', 'yet', 'investigated.', 'This', 'study', 'perform', 'assess', 'knowledge', 'attitudes', 'medical', 'staff', 'two', 'Chinese', 'mental', 'health', 'center', 'COVID-19', 'outbreak.', 'We', 'include', '141', 'psychiatrists', '170', 'psychiatric', 'nurse', 'study.', 'We', 'find', 'COVID-19', 'epidemic,', '89.51%', 'medical', 'staff', 'psychiatric', 'hospitals', 'study', 'extensive', 'knowledge', 'COVID-19,', '64.63%', 'receive', 'relevant', 'train', 'hospitals.', 'Furthermore,', '77.17%', 'participants', 'express', 'willingness', 'care', 'psychiatric', 'patients', 'suffer', 'COVID-19', 'virus', 'infection.', 'Independent', 'predictors', 'willingness', 'care', 'patients', 'include', 'advance', 'train', 'experience', 'care', 'patients', 'COVID-19.', 'In', 'conclusion,', 'study', 'suggest', 'increase', 'attention', 'pay', 'knowledge', 'attitudes', 'medical', 'staff', 'psychiatric', 'hospitals', 'COVID-19', 'outbreak.']"
DOI:10.1016/j.numecd.2020.04.013,2020-04-18T00:00:00.000Z,Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19,"Abstract Background A novel coronavirus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) caused pneumonia, Coronavirus Disease 2019 (COVID-19), outbroke in Wuhan, China in December 2019, and spread all over the world. Patients with COVID-19 showed huge differences in the hospital stays, progression and prognosis. As reported, the comorbidities may play an important role in COVID-19. Here, we aim to address the role of cardiovascular disease (CVD) in the progression and prognosis of COVID-19. Methods 83 confirmed COVID-19 patients were divided into the CVD (n=42) and non-CVD (n=41) group according to their medical history. Medical records information including demographic data, medical history, clinical characteristics, laboratory examinations, chest computed tomography (CT) as well as treatment measures were collected, analyzed and compared between two groups. Results COVID-19 patients with CVD showed: (1) more severe pathological changes in the lung, (2) elevated injury-related enzymes including α-hydroxybutyrate dehydrogenase (HDBH), lactate dehydrogenase (LDH), γ-glutamyltransferase (GGT), creatine kinase (CK) and alanine aminotransferase (ALT), (3) significantly increased uncontrolled inflammation related markers, such as c-reactive protein (CRP), interleukin (IL)-6, serum ferritin, erythrocyte sedimentation rate (ESR) and serum amyloid A (SAA), (4) serious hypercoagulable status reflected by increased D-dimer and serum fibrinogen (FIB), and (5) higher mortality, compared to COVID-19 patients without CVD. Conclusions Our data indicated that CVD is a strong risk factor for a rapid progression and bad prognosis of COVID-19. More intensive medical care should be applied to patients with CVD to prevent rapid deterioration of the disease.","Nutrition, Metabolism and Cardiovascular Diseases",Mingyue Li,"{'author': [{'$': 'Mingyue Li'}, {'$': 'Yalan Dong'}, {'$': 'Haijun Wang'}, {'$': 'Weina Guo'}, {'$': 'Desheng Hu'}]}",https://api.elsevier.com/content/article/pii/S0939475320301344,10.1016/j.numecd.2020.04.013,Open,S0939475320301344,"['Cardiovascular', 'disease', 'potentially', 'contribute', 'progression', 'poor', 'prognosis', 'COVID-19']","['Abstract', 'Background', 'A', 'novel', 'coronavirus', 'severe', 'acute', 'respiratory', 'syndrome', 'corona', 'virus', '2', '(SARS-CoV-2)', 'cause', 'pneumonia,', 'Coronavirus', 'Disease', '2019', '(COVID-19),', 'outbroke', 'Wuhan,', 'China', 'December', '2019,', 'spread', 'world.', 'Patients', 'COVID-19', 'show', 'huge', 'differences', 'hospital', 'stays,', 'progression', 'prognosis.', 'As', 'reported,', 'comorbidities', 'may', 'play', 'important', 'role', 'COVID-19.', 'Here,', 'aim', 'address', 'role', 'cardiovascular', 'disease', '(CVD)', 'progression', 'prognosis', 'COVID-19.', 'Methods', '83', 'confirm', 'COVID-19', 'patients', 'divide', 'CVD', '(n=42)', 'non-CVD', '(n=41)', 'group', 'accord', 'medical', 'history.', 'Medical', 'record', 'information', 'include', 'demographic', 'data,', 'medical', 'history,', 'clinical', 'characteristics,', 'laboratory', 'examinations,', 'chest', 'compute', 'tomography', '(CT)', 'well', 'treatment', 'measure', 'collected,', 'analyze', 'compare', 'two', 'groups.', 'Results', 'COVID-19', 'patients', 'CVD', 'showed:', '(1)', 'severe', 'pathological', 'change', 'lung,', '(2)', 'elevate', 'injury-related', 'enzymes', 'include', 'α-hydroxybutyrate', 'dehydrogenase', '(HDBH),', 'lactate', 'dehydrogenase', '(LDH),', 'γ-glutamyltransferase', '(GGT),', 'creatine', 'kinase', '(CK)', 'alanine', 'aminotransferase', '(ALT),', '(3)', 'significantly', 'increase', 'uncontrolled', 'inflammation', 'relate', 'markers,', 'c-reactive', 'protein', '(CRP),', 'interleukin', '(IL)-6,', 'serum', 'ferritin,', 'erythrocyte', 'sedimentation', 'rate', '(ESR)', 'serum', 'amyloid', 'A', '(SAA),', '(4)', 'serious', 'hypercoagulable', 'status', 'reflect', 'increase', 'D-dimer', 'serum', 'fibrinogen', '(FIB),', '(5)', 'higher', 'mortality,', 'compare', 'COVID-19', 'patients', 'without', 'CVD.', 'Conclusions', 'Our', 'data', 'indicate', 'CVD', 'strong', 'risk', 'factor', 'rapid', 'progression', 'bad', 'prognosis', 'COVID-19.', 'More', 'intensive', 'medical', 'care', 'apply', 'patients', 'CVD', 'prevent', 'rapid', 'deterioration', 'disease.']"
DOI:10.1016/j.scitotenv.2020.138436,2020-04-04T00:00:00.000Z,"Correlation between weather and Covid-19 pandemic in Jakarta, Indonesia","
               Abstract
               
                  This study aims to analyze the correlation between weather and covid-19 pandemic in Jakarta Indonesia. This study employed a secondary data analysis of surveillance data of covid-19 from the Ministry of Health of the Republic of Indonesia and weather from the Meteorological Department of the Republic of Indonesia. The components of weather include minimum temperature (°C), maximum temperature (°C), temperature average (°C), humidity (%), and amount of rainfall (mm). Spearman-rank correlation test was used for data analysis. Among the components of the weather, only temperature average (°C) was significantly correlated with covid-19 pandemic (r = 0.392; p < .01). The finding serves as an input to reduce the incidence rate of covid-19 in Indonesia.
               
            ",Science of The Total Environment,Ramadhan Tosepu,"{'author': [{'$': 'Ramadhan Tosepu'}, {'$': 'Joko Gunawan'}, {'$': 'Devi Savitri Effendy'}, {'$': 'La Ode Ali Imran Ahmad'}, {'$': 'Pitrah Asfian'}]}",https://api.elsevier.com/content/article/pii/S0048969720319495,10.1016/j.scitotenv.2020.138436,Private,S0048969720319495,"['Correlation', 'weather', 'Covid-19', 'pandemic', 'Jakarta,', 'Indonesia']","['Abstract', 'This', 'study', 'aim', 'analyze', 'correlation', 'weather', 'covid-19', 'pandemic', 'Jakarta', 'Indonesia.', 'This', 'study', 'employ', 'secondary', 'data', 'analysis', 'surveillance', 'data', 'covid-19', 'Ministry', 'Health', 'Republic', 'Indonesia', 'weather', 'Meteorological', 'Department', 'Republic', 'Indonesia.', 'The', 'components', 'weather', 'include', 'minimum', 'temperature', '(°C),', 'maximum', 'temperature', '(°C),', 'temperature', 'average', '(°C),', 'humidity', '(%),', 'amount', 'rainfall', '(mm).', 'Spearman-rank', 'correlation', 'test', 'use', 'data', 'analysis.', 'Among', 'components', 'weather,', 'temperature', 'average', '(°C)', 'significantly', 'correlate', 'covid-19', 'pandemic', '(r', '=', '0.392;', 'p', '<', '.01).', 'The', 'find', 'serve', 'input', 'reduce', 'incidence', 'rate', 'covid-19', 'Indonesia.']"
DOI:10.1016/j.jdermsci.2020.04.011,2020-04-29T00:00:00.000Z,Cutaneous manifestations of COVID-19: Report of three cases and a review of literature,"
               ABSTRACT
               
                  Background
                  Various cutaneous manifestations have been observed in patients with COVID-19 infection. However, overall similarities in the clinical presentation of these dermatological manifestations have not yet been summarized.
               
               
                  Objective
                  This review aims to provide an overview of various cutaneous manifestations in patients with COVID-19 through three case reports and a literature review.
               
               
                  Methods
                  A literature search was conducted using PubMed, OVID, and Google search engines for original and review articles. Studies written in the English language that mentioned cutaneous symptoms and COVID-19 were included.
               
               
                  Results
                  Eighteen articles and three additional cases reported in this paper were included in this review. Of these studies, 6 are case series and 12 are case report studies. The most common cutaneous manifestation of COVID-19 was found to be maculopapular exanthem (morbilliform), presenting in 36.1% (26/72) patients. The other cutaneous manifestations included: a papulovesicular rash (34.7%, 25/72), urticaria (9.7%, 7/72), painful acral red purple papules (15.3%, 11/72) of patients, livedo reticularis lesions (2.8%, 2/72) and petechiae (1.4%, 1/72). Majority of lesions were localized on the trunk (66.7%, 50/72), however, 19.4% (14/72) of patients experienced cutaneous manifestations in the hands and feet. Skin lesion development occurred after the onset of respiratory symptoms or before COVID-19 diagnosis in 12.5% (9/72) of the patients, and lesions spontaneously healed in all patients within 10 days. Majority of the studies reported no correlation between COVID-19 severity and skin lesions.
               
               
                  Conclusion
                  Infection with COVID-19 may result in dermatological manifestations with various clinical presentations, which may aid in the timely diagnosis of this infection.
               
            ",Journal of Dermatological Science,Muskaan Sachdeva,"{'author': [{'$': 'Muskaan Sachdeva'}, {'$': 'Raffaele Gianotti'}, {'$': 'Monica Shah'}, {'$': 'Bradanini Lucia'}, {'$': 'Roni P. Dodiuk-Gad'}]}",https://api.elsevier.com/content/article/pii/S0923181120301493,10.1016/j.jdermsci.2020.04.011,Private,S0923181120301493,"['Cutaneous', 'manifestations', 'COVID-19:', 'Report', 'three', 'case', 'review', 'literature']","['ABSTRACT', 'Background', 'Various', 'cutaneous', 'manifestations', 'observe', 'patients', 'COVID-19', 'infection.', 'However,', 'overall', 'similarities', 'clinical', 'presentation', 'dermatological', 'manifestations', 'yet', 'summarized.', 'Objective', 'This', 'review', 'aim', 'provide', 'overview', 'various', 'cutaneous', 'manifestations', 'patients', 'COVID-19', 'three', 'case', 'report', 'literature', 'review.', 'Methods', 'A', 'literature', 'search', 'conduct', 'use', 'PubMed,', 'OVID,', 'Google', 'search', 'engines', 'original', 'review', 'articles.', 'Studies', 'write', 'English', 'language', 'mention', 'cutaneous', 'symptoms', 'COVID-19', 'included.', 'Results', 'Eighteen', 'article', 'three', 'additional', 'case', 'report', 'paper', 'include', 'review.', 'Of', 'studies,', '6', 'case', 'series', '12', 'case', 'report', 'studies.', 'The', 'common', 'cutaneous', 'manifestation', 'COVID-19', 'find', 'maculopapular', 'exanthem', '(morbilliform),', 'present', '36.1%', '(26/72)', 'patients.', 'The', 'cutaneous', 'manifestations', 'included:', 'papulovesicular', 'rash', '(34.7%,', '25/72),', 'urticaria', '(9.7%,', '7/72),', 'painful', 'acral', 'red', 'purple', 'papules', '(15.3%,', '11/72)', 'patients,', 'livedo', 'reticularis', 'lesions', '(2.8%,', '2/72)', 'petechiae', '(1.4%,', '1/72).', 'Majority', 'lesions', 'localize', 'trunk', '(66.7%,', '50/72),', 'however,', '19.4%', '(14/72)', 'patients', 'experience', 'cutaneous', 'manifestations', 'hand', 'feet.', 'Skin', 'lesion', 'development', 'occur', 'onset', 'respiratory', 'symptoms', 'COVID-19', 'diagnosis', '12.5%', '(9/72)', 'patients,', 'lesions', 'spontaneously', 'heal', 'patients', 'within', '10', 'days.', 'Majority', 'study', 'report', 'correlation', 'COVID-19', 'severity', 'skin', 'lesions.', 'Conclusion', 'Infection', 'COVID-19', 'may', 'result', 'dermatological', 'manifestations', 'various', 'clinical', 'presentations,', 'may', 'aid', 'timely', 'diagnosis', 'infection.']"
